Kanvas Biosciences, Inc.
Imaging technology platform to map the microbiome and develop microbiome-based therapeutics
- Sector
- Biotech
- Headquarters
- MONMOUTH JUNCTION, NJ
- Founded
- 2020
- Latest Form D
- $3.9M, Mar 2024
- Total capital
- $15.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $15.7M
- 2 Form D · last Mar 2024
- 31 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 29 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$3.9M
- Private capital raisedForm D · SEC · 1st filing$11.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Hao ShiExecutive Officer, DirectorNamed in SEC Form D filings
- Iwijn De VlaminckExecutive Officer, DirectorNamed in SEC Form D filings
- Jason PontinDirectorNamed in SEC Form D filings
- Justin SmithlineDirectorNamed in SEC Form D filings
- Matthew ChengExecutive Officer, DirectorNamed in SEC Form D filings
- Paul TheunissenDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 29- PendingMicrobial ConsortiaUSPTOApplication 19381263
- PendingSpatial Characterization Of The Fecal MicrobiomeUSPTOApplication 19288083
- PendingMicrobial ConsortiaUSPTOApplication 19324836
Show all 29 patent records
- Microbial ConsortiaJul 9, 2026 · Application 19381263Pending
- Spatial Characterization Of The Fecal MicrobiomeFeb 5, 2026 · Application 19288083Pending
- Microbial ConsortiaJan 8, 2026 · Application 19324836Pending
- Highly Multiplexed Detection Of Gene Expression With Hybridization Chain ReactionAug 24, 2023 · Application 18171850Pending
- High-complexity Synthetic Gut Bacterial CommunitiesJul 27, 2023 · Application 17999516Pending
- Multiplexed Fluorescence In Situ Hybridization Method Capable Of Rapid Detection Of Billions Of TargetsMay 25, 2023 · Application 18058171Pending
- Microbial Consortia For The Treatment Of DiseaseApr 27, 2023 · Application 17906060Pending
- Method for Assessing Viability of Microbial StrainsApplication 63720519Pending
- Microbial ConsortiaApplication 63716540Pending
- Method For Identifying Microbial StrainsApplication 63716534Pending
- Microbial Consortia For Treating Or Preventing Immune Checkpoint Inhibitor Associated Adverse EventsApplication 63682156Pending
- Spatial Characterization Of The Fecal MicrobiomeApplication 63678339Pending
- Screening For Host-microbe InteractionsApplication PCTUS2024022443Pending
- Microbial ConsortiaApplication PCTUS2024019341Pending
- Screening For Host-microbe InteractionsApplication 63493817Pending
- Highly Multiplexed Detection Of Gene Expression With Hybridization Chain ReactionApplication PCTUS2023062917Pending
- Microbial ConsortiaApplication PCTUS2022051477Pending
- A Multiplexed Fluorescence In Situ Hybridization Method Capable Of Rapid Detection Of Billions Of TargetsApplication PCTUS2022080355Pending
- Multiplexed Fluorescence In Situ Hybridization Method Capable Of Rapid Detection Of Billions Of TargetsApplication 63339291Pending
- Highly Multiplexed Detection Of Gene Expression With Hybridization Chain ReactionApplication 63317180Pending
- Highly Multiplexed Detection Of Gene Expression With Hybridization Chain ReactionApplication 63312253Pending
- Method For Assessing Viability Of Microbial StrainsApplication PCTUS2025055458Pending
- Rapid Identification Of Antimicrobial Resistance And Other Microbial Phenotypes Using Highly-multiplexed Fluorescence In Situ HybridizationApplication 63282947Pending
- Microbial ConsortiaApplication PCTUS2025054096Pending
- Method For Identifying Microbial StrainsApplication PCTUS2025054166Pending
- Screening For Host-microbe InteractionsApplication 19471569Pending
- Microbial Consortia For Treating Or Preventing Immune-related Adverse EventsApplication PCTUS2025041609Pending
- Spatial Characterization Of The Fecal MicrobiomeApplication PCTUS2025040259Pending
- Microbial ConsortiaApplication 63740454Pending
Related companies, and why
- Nalu Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Latent Labs Technologies, Inc.Similar federal contract value in Biotech · null in contracts
- Seek Laboratories, Inc.Similar federal contract value in Biotech · null in contracts
- Cantai Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- GeorgiamuneSimilar federal contract value in Biotech · null in contracts
- Rinascera Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .